Catalyst Wire Dossier Catalyst Wire Dossier

Nu-3

bisphosphocin · Lakewood-Amedex Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nu-3, covering 2019-11-19 to 2019-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus [Phase 1, Phase 2]

See pricing